Discovery and use of small molecules for probing biological processes in zebrafish

Methods in Cell Biology

Volumn 2004, Issue 76, 2004, Pages 569-591

  Peterson, Randall T ^a   Fishman, Mark C ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC COMPOUND;

AFFINITY CHROMATOGRAPHY; ANIMAL; ANIMAL EMBRYO; ARTICLE; COMBINATORIAL CHEMISTRY; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MORPHOGENESIS; MUTATION; PHENOTYPE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRENATAL DEVELOPMENT; ZEBRA FISH;

ANIMALS; CHROMATOGRAPHY, AFFINITY; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MORPHOGENESIS; MUTATION; ORGANIC CHEMICALS; PHENOTYPE; POLYMERASE CHAIN REACTION; ZEBRAFISH;

EID: 16644375807     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)76026-4     Document Type: Review

References (64)

1. Amatruda, J. F., Shepard, J. L., Stern, H. M., and Zon, L. I. (2002). Zebrafish as a cancer model system. Cancer Cell 1, 229-231.
2. Batra, S., Srinivasan, T., Rastogi, S. K., and Kundu, B. (2002). Identification of enzyme inhibitors using combinatorial libraries. Current Medicinal Chemistry 9, 307-319.
3. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S., and Schreiber, S. L. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758.
4. Brown, P. O., and Botstein, D. (1999). Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21, 33-37.
5. Chen, J. K., Lane, W. S., and Schreiber, S. L. (1999). The identification of myriocin-binding proteins. Chemistry & Biology 6, 221-235.
6. Chen, J. K., Taipale, J., Cooper, M. K., and Beachy, P. A. (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743-2748.
7. Ciruna, B., Weidinger, G., Knaut, H., Thisse, B., Thisse, C., Raz, E., and Schier, A. F. (2002). Production of maternal-zygotic mutant zebrafish by germ-line replacement. Proc. Natl. Acacl. Sci. USA 99, 14919-14924.
8. Clark, M. D., Hennig, S., Herwig, R., Clifton, S. W., Marra, M. A., Lehrach, H., Johnson, S. L., and Group, T. W. (2001). An oligonucleotide fingerprint normalized and expressed sequence tag characterized zebrafish cDNA library. Genome Res. 11, 1594-1602.
9. Crews, C. M., Collins, J. L., Lane, W. S., Snapper, M. L., and Schreiber, S. L. (1994). GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha. J. Biol. Chem. 269, 15411-15414.
10. Davis, J. M., Clay, H., Lewis, J. L., Ghori, N., Herbomel, P., and Ramakrishnan, L. (2002). Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17, 693-702.
11. Dodd, J., Jessell, T. M., and Placzek, M. (1998). The when and where of floor plate induction. Science 282, 1654-1657.
12. Driever, W., Solnica-Krezel, L., Schier, A. F., Neuhauss, S. C., Malicki, J., Stemple, D. L., Stainier, D. Y., Zwartkruis, F., Abdelilah, S., Rangini, Z., et al. (1996). A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123, 37-46.
13. Farber, S. A., Pack, M., Ho, S. Y., Johnson, I. D., Wagner, D. S., Dosch, R., Mullins, M. C., Hendrickson, H. S., Hendrickson, E. K., and Halpern, M. E. (2001). Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292, 1385-1388.
14. Garrity, D. M., Childs, S., and Fishman, M. C. (2002). The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 129, 4635-4645.
15. Haffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., Kane, D. A., Odenthal, J., van Eeden, F. J., Jiang, Y. J., Heisenberg, C. P., et al. (1996). The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36.
16. Harding, M. W., Galat, A., Uehling, D. E., and Schreiber, S. L. (1989). A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341, 758-760.
17. Johnson, S. L., and Weston, J. A. (1995). Temperature-sensitive mutations that cause stage-specific defects in Zebrafish fin regeneration. Genetics 141, 1583-1595.
18. Khersonsky, S. M., Jung, D.-W., Kang, T.-W., Walsh, D. P., Moon, H. S., Jo, H., Jacobson, E. M., Shetty, V., Neubert, T. A., and Chang, Y. T. (2003). Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125, 11804-11805.
19. Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J., and Schreiber, S. L. (2002). Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature 416, 653-657.
20. Kwok, B. H., Koh, B., Ndubuisi, M. I., Elofsson, M., and Crews, C. M. (2001). The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem. Biol. 8, 759-766.
21. Langheinrich, U. (2003). Zebrafish: A new model on the pharmaceutical catwalk. Bioessays 25, 904-912.
22. Lin, J., Sahakian, D. C., de Morais, S. M., Xu, J. J., Polzer, R. J., and Winter, S. M. (2003). The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Curr. Top. Med. Chem. 3, 1125-1154.
23. Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol Toxicol. Methods 44, 235-249.
24. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26.
25. Liu, J., Farmer, J. D., Jr., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
26. Llorens, O., Perez, J. J., and Villar, H. O. (2001). Toward the design of chemical libraries for mass screening biased against mutagenic compounds. J. Med. Chem. 44, 2793-2804.
27. Lo, J., Lee, S., Xu, M., Liu, F., Ruan, H., Eun, A., He, Y., Ma, W., Wang, W., Wen, Z., et al. (2003). 15000 unique zebrafish EST clusters and their future use in microarray for profiling gene expression patterns during embryogenesis. Genome Res. 13, 455-466.
28. MacRae, C. A., and Peterson, R. T. (2003). Zebrafish-based small molecule discovery. Chem. Biol. 10, 901-908.
29. Marton, M. J., DeRisi, J. L., Bennett, H. A., Iyer, V. R., Meyer, M. R., Roberts, C. J., Stoughton, R., Burchard, J., Slade, D., Dai, H., et al. (1998). Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4, 1293-1301.
30. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T., and MacRae, C. A. (2003). Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358.
31. Miller, D. K., Gillard, J. W., Vickers, P. J., Sadowski, S., Leveille, C., Mancini, J. A., Charleson, P., Dixon, R. A., Ford-Hutchinson, A. W., Fortin, R., et al. (1990). Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343, 278-281.
32. Moon, H. S., Jacobson, E. M., Khersonsky, S. M., Luzung, M. R., Walsh, D. P., Xiong, W., Lee, J. W., Parikh, P. B., Lam, J. C., Kang, T. W., et al. (2002). A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 124, 11608-11609.
33. Mullins, M. C., Hammerschmidt, M., Haffter, P., and Nusslein-Volhard, C. (1994). Large-scale mutagenesis in the zebrafish: In search of genes controlling development in a vertebrate. Curr. Biol. 4, 189-202.
34. Nasevicius, A., and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. [see comments.]. Nature Genetics 26, 216-220.
35. Nguyen, C., Teo, J. L., Matsuda, A., Eguchi, M., Chi, E. Y., Henderson, W. R., Jr., and Kahn, M. (2003). Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc. Natl. Acad. Sci. USA 100, 1169-1173.
36. Nicolaou, K. C., and Pfefferkorn, J. A. (2001). Solid phase synthesis of complex natural products and libraries thereof. Biopolymers 60, 171-193.
37. Nusslein-Volhard, C., and Dahm, R. (2002). Zebrafish. Oxford University Press, Oxford.
38. Oprea, T. I. (2000). Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des. 14, 251-264.
39. Peterson, R. T., Link, B. A., Dowling, J. E., and Schreiber, S. L. (2000). Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 97, 12965-12969.
40. Peterson, R. T., Mably, J. D., Chen, J. N., and Fishman, M. C. (2001). Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Current Biology 11, 1481-1491.
41. Peterson, R. T., Shaw, S. Y., Peteron, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A., and Fishman, M. C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22, 595-599.
42. Poggesi, I. (2004). Predicting human pharmacokinetics from preclinical data. Curr. Opin. Drug Discov. Devel. 7, 100-111.
43. Postlethwait, J. H., Yan, Y. L., Gates, M. A., Home, S., Amores, A., Brownlie, A., Donovan, A., Egan, E. S., Force, A., Gong, Z., et al. (1998). Vertebrate genome evolution and the zebrafish gene map. Nat. Genet. 18, 345-349.
44. Roman, B. L., Pham, V. N., Lawson, N. D., Kulik, M., Childs, S., Lekven, A. C., Garrity, D. M., Moon, R. T., Fishman, M. C., Lechleider, R. J., et al. (2002). Disruption of acvr11 increases endothelial cell number in zebrafish cranial vessels. Development 129, 3009-3019.
45. Rubinstein, A. L. (2003). Zebrafish: From disease modeling to drug discovery. Curr. Opin. Drug Discov. Devel. 6, 218-223.
46. Schauerte, H. E., van Eeden, F. J., Fricke, C., Odenthal, J., Strahle, U., and Haffter, P. (1998). Sonic hedgehog is not required for the induction of medial floor plate cells in the zebrafish. Development 125, 2983-2993.
47. Shimizu, N., Sugimoto, K., Tang, J., Nishi, T., Sato, I., Hiramoto, M., Aizawa, S., Hatakeyama, M., Ohba, R., Hatori, H., et al. (2000). High-performance affinity beads for identifying drug receptors. Nat. Biotechnol. 18, 877-881.
48. Shin, J. T., and Fishman, M. C. (2002). From Zebrafish to human: Modular medical models. Annu. Rev. Genomics. Hum. Genet. 3, 311-340.
49. Spring, D. R., Krishnan, S., Blackwell, H. E., and Schreiber, S. L. (2002). Diversity-oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. J. Am. Chem. Soc. 124, 1354-1363.
50. St Johnston, D. (2002). The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3, 176-188.
51. Stern, H. M., and Zon, L. I. (2003). Cancer genetics and drug discovery in the zebrafish. Nat. Rev. Cancer 3, 533-539.
52. Sternson, S. M., Louca, J. B., Wong, J. C., and Schreiber, S. L. (2001). Split-pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays. J. Am. Chem. Soc. 123, 1740-1747.
53. Talbot, W. S., and Schier, A. F. (1999). Positional cloning of mutated zebrafish genes. Methods Cell Biol. 60, 259-286.
54. Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996). A mammalian hist one deacetylase related to the yeast transcriptional regulator Rpd3p. [see comments.] Science 272, 408-411.
55. Taylor, J. S., Braasch, I. , Frickey, T., Meyer, A., and Van de Peer, Y. (2003). Genome duplication, a trait shared by 22000 species of ray-finned fish. Genome Res. 13, 382-390.
56. Ton, C., Stamatiou, D., Dzau, V. J., and Liew, C. C. (2002). Construction of a zebrafish cDNA microarray: Gene expression profiling of the zebrafish during development. Biochem. Biophys. Res. Commun. 296, 1134-1142.
57. van de Waterbeemd, H., and Gifford, E. (2003). ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discov. 2, 192-204.
58. Van Der Sar, A. M., Musters, R. J., Van Eeden, F. J., Appelmelk, B. J., Vandenbroucke-Grauls, C. M., and Bitter, W. (2003). Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol. 5, 601-611.
59. van Eeden, F. J., Granato, M., Schach, U., Brand, M., Furutani-Seiki, M., Haffter, P., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J., Kane, D. A., et al. (1996). Mutations affecting somite formation and patterning in the zebrafish, Danio rerio. Development 123, 153-164.
60. Weinstein, B. M., Stemple, D. L., Driever, W., and Fishman, M. C. (1995). Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat. Med. 1, 1143-1147.
61. Wienholds, E., Schulte-Merker, S., Walderich, B., and Plasterk, R. H. (2002). Target-selected inactivation of the zebrafish rag1 gene. Science 297, 99-102.
62. Wolff, C., Roy, S., and Ingham, P. W. (2003). Multiple muscle cell identities induced by distinct levels and timing of hedgehog activity in the zebrafish embryo. Curr. Biol. 13, 1169-1181.
63. Xu, X., Meiler, S. E., Zhong, T. P., Mohideen, M., Crossley, D. A., Burggren, W. W., and Fishman, M. C. (2002). Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nature Genetics 30, 205-209.
64. Yu, H., and Adedoyin, A. (2003). ADME-Tox in drug discovery: Integration of experimental and computational technologies. Drug Discor. Today 8, 852-861.